How to buy Anchiano Therapeutics stock - 19 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Anchiano Therapeutics stock

Own Anchiano Therapeutics stock in just a few minutes.

Anchiano Therapeutics Ltd is a biotechnology business based in the US. Anchiano Therapeutics shares (ANCN) are listed on the NASDAQ and all prices are listed in US Dollars. Anchiano Therapeutics employs 3 staff and has a market cap (total outstanding shares value) of USD0.00.

How to buy shares in Anchiano Therapeutics

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Anchiano Therapeutics. Find the stock by name or ticker symbol: ANCN. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Anchiano Therapeutics reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Anchiano Therapeutics, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Anchiano Therapeutics. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Anchiano Therapeutics share price

Use our graph to track the performance of ANCN stocks over time.

Anchiano Therapeutics shares at a glance

Information last updated 2021-04-04.
52-week rangeUSD$11.20 - USD$94.40
50-day moving average USD$61.36
200-day moving average USD$34.74
Wall St. target priceUSD$1.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-5.21

Buy Anchiano Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Gold/Commodities
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Anchiano Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Anchiano Therapeutics financials

Gross profit TTM USD$0
Return on assets TTM -52.84%
Return on equity TTM -125.6%
Profit margin 0%
Book value $7.71
Market capitalisation USD$34.9 million

TTM: trailing 12 months

Shorting Anchiano Therapeutics shares

There are currently 65,165 Anchiano Therapeutics shares held short by investors – that's known as Anchiano Therapeutics's "short interest". This figure is 65.7% down from 190,175 last month.

There are a few different ways that this level of interest in shorting Anchiano Therapeutics shares can be evaluated.

Anchiano Therapeutics's "short interest ratio" (SIR)

Anchiano Therapeutics's "short interest ratio" (SIR) is the quantity of Anchiano Therapeutics shares currently shorted divided by the average quantity of Anchiano Therapeutics shares traded daily (recently around 3.3 million). Anchiano Therapeutics's SIR currently stands at 0.02. In other words for every 100,000 Anchiano Therapeutics shares traded daily on the market, roughly 20 shares are currently held short.

However Anchiano Therapeutics's short interest can also be evaluated against the total number of Anchiano Therapeutics shares, or, against the total number of tradable Anchiano Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Anchiano Therapeutics's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Anchiano Therapeutics shares in existence, roughly 10 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Anchiano Therapeutics shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Anchiano Therapeutics.

Find out more about how you can short Anchiano Therapeutics stock.

Anchiano Therapeutics share dividends

We're not expecting Anchiano Therapeutics to pay a dividend over the next 12 months.

Anchiano Therapeutics share price volatility

Over the last 12 months, Anchiano Therapeutics's shares have ranged in value from as little as $11.2002 up to $94.4. A popular way to gauge a stock's volatility is its "beta".

ANCN.US volatility(beta: 0.96)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Anchiano Therapeutics's is 0.9598. This would suggest that Anchiano Therapeutics's shares are less volatile than average (for this exchange).

Anchiano Therapeutics overview

Anchiano Therapeutics Ltd. , a preclinical biotechnology company, discovers, develops, and commercializes small molecule anti-cancer therapeutics. It primarily develops Pan-RAS Program that identifies novel indene-based small molecules that exhibit potent and selective inhibition of activated RAS signaling regardless of isoform or mutation; and PDE10/ß-catenin program, which identifies small molecules that selectively and potently inhibit PDE10 and suppress Wnt/APC/ß-catenin signaling in preclinical models. Anchiano Therapeutics Ltd. has collaboration and license agreement with ADT Pharmaceuticals, LLC to research and develop programs related to the pan-RAS and PDE10/ß-catenin programs. The company was formerly known as BioCancell Ltd. and changed its name Anchiano Therapeutics Ltd.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site